Variant report
Variant | rs10771769 |
---|---|
Chromosome Location | chr12:30910280-30910281 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:30)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:30 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | RCOR1 | chr12:30909719-30910774 | K562 | blood: | n/a | n/a |
2 | STAT5A | chr12:30910168-30910652 | K562 | blood: | n/a | n/a |
3 | GATA2 | chr12:30910166-30910689 | K562 | blood: | n/a | n/a |
4 | PML | chr12:30910181-30910612 | K562 | blood: | n/a | n/a |
5 | MXI1 | chr12:30910037-30910499 | K562 | blood: | n/a | n/a |
6 | HMGN3 | chr12:30910249-30910597 | K562 | blood: | n/a | n/a |
7 | TAL1 | chr12:30909918-30910700 | K562 | blood: | n/a | n/a |
8 | STAT5A | chr12:30910240-30910597 | K562 | blood: | n/a | n/a |
9 | CEBPD | chr12:30910244-30910734 | K562 | blood: | n/a | n/a |
10 | TRIM28 | chr12:30910183-30910697 | K562 | blood: | n/a | n/a |
11 | TEAD4 | chr12:30910220-30910701 | K562 | blood: | n/a | n/a |
12 | JUND | chr12:30909939-30910587 | K562 | blood: | n/a | chr12:30910495-30910504 chr12:30910557-30910569 |
13 | RCOR1 | chr12:30910073-30910565 | K562 | blood: | n/a | n/a |
14 | PML | chr12:30910209-30910576 | K562 | blood: | n/a | n/a |
15 | TBL1XR1 | chr12:30909915-30910611 | K562 | blood: | n/a | n/a |
16 | SPI1 | chr12:30910266-30910512 | GM12878 | blood: | n/a | n/a |
17 | MAFK | chr12:30910138-30910503 | K562 | blood: | n/a | n/a |
18 | CEBPD | chr12:30910231-30910695 | K562 | blood: | n/a | n/a |
19 | CCNT2 | chr12:30910253-30910596 | K562 | blood: | n/a | n/a |
20 | GATA1 | chr12:30909225-30910827 | PBDE | blood: | n/a | n/a |
21 | ARID3A | chr12:30909897-30910593 | K562 | blood: | n/a | n/a |
22 | NR2F2 | chr12:30910233-30910630 | K562 | blood: | n/a | n/a |
23 | MYC | chr12:30910120-30910649 | K562 | blood: | n/a | n/a |
24 | CEBPB | chr12:30910256-30910608 | K562 | blood: | n/a | n/a |
25 | MYC | chr12:30910268-30910671 | K562 | blood: | n/a | n/a |
26 | TEAD4 | chr12:30910190-30910697 | K562 | blood: | n/a | n/a |
27 | POLR2A | chr12:30909641-30910682 | PBDE | blood: | n/a | n/a |
28 | GATA1 | chr12:30909837-30910843 | K562 | blood: | n/a | n/a |
29 | EP300 | chr12:30909890-30910659 | K562 | blood: | n/a | n/a |
30 | POLR2A | chr12:30910082-30910349 | GM12878 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CAPRIN2 | TF binding region |
ENSG00000133704 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10734791 | 0.85[ASN][1000 genomes] |
rs10743733 | 0.81[AFR][1000 genomes];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs10743734 | 0.97[AFR][1000 genomes];0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs10771754 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs10771758 | 0.81[ASN][1000 genomes] |
rs10771759 | 0.85[ASN][1000 genomes] |
rs10771764 | 0.91[AFR][1000 genomes];0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs11051013 | 0.84[EUR][1000 genomes] |
rs11051052 | 0.90[AMR][1000 genomes];0.87[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12370429 | 0.80[AFR][1000 genomes];0.84[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs13656 | 0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs1371049 | 0.85[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs1371053 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs1866416 | 0.89[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs2099661 | 0.83[ASN][1000 genomes] |
rs2289301 | 0.84[AMR][1000 genomes];0.85[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs2304630 | 0.84[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs2352210 | 0.82[EUR][1000 genomes] |
rs2352217 | 0.87[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs33132 | 0.84[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs3782685 | 0.83[AMR][1000 genomes];0.85[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs4143103 | 0.82[EUR][1000 genomes] |
rs4930935 | 0.84[AMR][1000 genomes];0.86[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4930936 | 0.80[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4931356 | 0.81[EUR][1000 genomes] |
rs6487932 | 0.84[AMR][1000 genomes];0.87[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6487933 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs7136079 | 0.86[AFR][1000 genomes];0.85[AMR][1000 genomes];0.89[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs718368 | 0.85[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7297455 | 0.86[ASN][1000 genomes] |
rs7298007 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7298180 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs7304879 | 0.85[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs7304976 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes] |
rs7311651 | 0.97[AFR][1000 genomes];0.98[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs7963494 | 0.81[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7968587 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs9300199 | 0.83[AMR][1000 genomes];0.86[EUR][1000 genomes];0.83[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv3343291 | chr12:30455597-30992837 | Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
2 | nsv832361 | chr12:30794030-30997241 | Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
3 | nsv949148 | chr12:30800040-31131712 | Strong transcription Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 45 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30908600-30911400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr12:30908800-30915200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr12:30909200-30914800 | Weak transcription | HepG2 | liver |
4 | chr12:30909600-30915800 | Weak transcription | Pancreas | Pancrea |
5 | chr12:30909800-30910800 | Flanking Active TSS | K562 | blood |